Review: The role of insulin resistance in nonalcoholic fatty liver disease.

By K. Utzschneider, S. Kahn. Journal of Clinical Endocrinology and Metabolism, 2006

836 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/eb8fb0dcc3f06f214f76da323fe7e4bf40b5146e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. J. Lambert
2. Chung S. Yang
3. Xingjun Huang
4. Jiao Guo
5. Jihyeung Ju
6. K. Reuhl
7. Guihua Liu
8. S. Shapses

Citations in the corpus

• The Major Green Tea Polyphenol, (−)-Epigallocatechin-3-Gallate, Inhibits Obesity, Metabolic Syndrome, and Fatty Liver Disease in High-Fat–Fed Mice, (2008, background): “Insulin resistance causes increased plasma FFA and enhances liver uptake of fatty acids, which are then stored as triglycerides (34).”
• Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus (2016, neutral): “1) mg/dL 119 (24) 110 (14) −11 (−19 to −2) 2-h plasma glucose level <0.”
• The PI3K/AKT pathway in obesity and type 2 diabetes (2018, background): “PI3K, Phosphoinositide 3-kinase; AKT, protein kinase B; T2DM, type 2 diabetes mellitus; RTKs, receptor tyrosine kinases; GPCR, G-protein-coupled receptors; PIP2, phosphatidylinositol 4,5-biphosphate; PIP3, phosphatidylinositol 3,4,5-triphosphate; PTEN, Phosphatase and tensin homologue; PDK1, phospho”